Health & Environmental Research Online (HERO)


Print Feedback Export to File
7422947 
Journal Article 
HER3 
Lugovskoy, A; Curley, M; Lahdenranta, J; Kalra, A; Czibere, A; Macbeath, G; Schoeberl, B; , 
2015 
Springer New York 
New York, NY 
Cancer Therapeutic Targets 
1-19 
ErbB3/HER3 belongs to the family of ErbB receptors, which comprises  four transmembrane receptors that can bind more than ten different ligands. The ErbB3 receptor forms heterodimers with the other ErbB receptor family members, which is the necessary step to activate downstream prosurvival signaling. While ErbB3 signaling plays an important role in embryonic development, it has also been implicated in the development of cancer and in mediating resistance to anti-cancer treatments. In this chapter, we  summarize the state of anti-ErbB3 therapies currently in clinical development including the emerging clinical data on HRG mRNA as a potential prognostic and predictive biomarker.